Welcome to our dedicated page for Baker Hughes Co SEC filings (Ticker: BKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Baker Hughes Company (NASDAQ: BKR) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations as an energy technology company. On this SEC filings page, Stock Titan connects those disclosures with AI-powered tools to help readers interpret complex regulatory language and identify key points.
For Baker Hughes, current reports on Form 8-K are particularly important. Recent 8-K filings describe material events such as the Agreement and Plan of Merger under which Baker Hughes will acquire Chart Industries, Inc., related financing arrangements including a term loan credit agreement and bridge commitment letter, and the expiration of the Hart-Scott-Rodino waiting period for the proposed transaction. Other 8-Ks cover quarterly results, conference call details, and changes in senior leadership roles within its Industrial & Energy Technology organization.
In addition to 8-Ks, investors typically review Baker Hughes’ annual reports on Form 10-K and quarterly reports on Form 10-Q for segment performance, risk factors, remaining performance obligations, and discussions of its oilfield services and equipment and industrial and energy technology segments. The company also has registered 5.125% Senior Notes due 2040 of Baker Hughes Holdings LLC and Baker Hughes Co-Obligor, Inc. on Nasdaq under the symbol BKR40, which are reflected in its filings.
Stock Titan’s platform provides real-time access to new Baker Hughes filings from EDGAR and uses AI to summarize lengthy documents such as 10-Ks, 10-Qs, and key 8-Ks. Users can quickly see the main topics in each filing, such as merger terms, financing commitments, or segment results, and can review insider and capital structure information where disclosed. This helps readers navigate Baker Hughes’ regulatory history and understand the implications of its filings without reading every page in full.
Baker Hughes Chief Legal Officer Maria Georgia Magno reported equity award activity in Class A Common Stock. On January 26, 2026, 2,654 restricted stock units vested and were converted into 2,654 shares of Class A Common Stock, increasing her directly owned stake to 24,992.296 shares.
On the same date, 779 shares of Class A Common Stock were withheld at a price of $56.29 per share, indicated as a tax-related transaction, leaving 24,213.296 shares of Class A Common Stock directly owned after these transactions. The RSU vesting represents the last of three equal annual installments from a grant dated January 24, 2023.
Baker Hughes Chairman, President and CEO Lorenzo Simonelli reported equity transactions in Class A Common Stock. On January 26, 2026, 50,857 restricted stock units were converted into the same number of Class A shares at an exercise price of $0.00 per share.
On the same date, 17,401 Class A shares were disposed of at $56.29 per share under transaction code "F". After these transactions, Simonelli directly owned 701,049 shares of Baker Hughes Class A Common Stock. Each restricted stock unit represented one share, and this vesting was the last of three equal annual installments from a January 24, 2023 grant.
Baker Hughes Executive Vice President and Chief Financial Officer Moghal Ahmed Farhan reported equity transactions in the company’s Class A Common Stock. On January 26, 2026, 3,843 restricted stock units vested, converting into 3,843 shares of Class A Common Stock, representing the final installment of a grant made on January 24, 2023.
To cover tax obligations, 1,052 of these shares were withheld at a price of $56.29 per share. After these transactions, Farhan directly held 19,145 shares of Class A Common Stock and indirectly held 18,102 shares through his spouse.
Baker Hughes Company furnished an earnings news release covering its financial results for the quarter and year ended December 31, 2025. The release is provided as Exhibit 99.1 to this Form 8-K and is treated as “furnished,” not “filed,” under securities law, which affects how it may be used in certain legal contexts.
The company plans to discuss these fourth-quarter and full-year 2025 results on a conference call on January 26, 2026, which will be webcast live via its investor website, with an archived replay available for one month. The release and call reference both GAAP figures and non-GAAP financial measures, with reconciliations to the nearest GAAP measures included in the news release.
JPMorgan Chase & Co. reported its ownership position in Baker Hughes Company, stating that it beneficially owned 86,781,218 shares of Baker Hughes Class A common stock, representing 8.7% of the class as of 12/31/2025. JPMorgan disclosed sole voting power over 74,674,028 shares and shared voting power over 1,148,080 shares.
The firm also reported sole dispositive power over 86,049,138 shares and shared dispositive power over 732,073 shares. JPMorgan certified that the shares are held in the ordinary course of business and are not held for the purpose of changing or influencing control of Baker Hughes.
A shareholder of BKR has filed a notice of proposed sale on Form 144 covering 25,000 Class A shares. The shares are listed for sale through Fidelity Brokerage Services LLC on the NASDAQ, with an indicated aggregate market value of $1,377,250.00. The filing lists the approximate sale date as 01/23/2026.
These shares were originally acquired from the issuer on 01/24/2025 through restricted stock vesting, classified as compensation. The person for whose account the securities are to be sold represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Baker Hughes Co (BKR) disclosed a director’s updated equity holdings and compensation-related awards. The director is reported as indirectly owning 18,023 shares of Class A common stock through Cannonbury Investments Limited, with this amount including 153 shares acquired via a dividend reinvestment plan. On December 15, 2025, the director also acquired 3,554.045 Deferred Stock Units, each representing the right to receive one share of Class A common stock. These Deferred Stock Units were fully vested on the grant date and reflect the director’s election to receive 2025 retainer fees in stock, with delivery of the shares deferred until the director ceases to serve on the board.
Baker Hughes Co director reported several equity transactions dated 12/15/2025. The director received 6,377 and 3,932 shares of Class A Common Stock through the settlement of previously granted Restricted Stock Units and Deferred Stock Units, bringing beneficial ownership to 10,309 directly held shares. The director was also credited with 3,447.994 Deferred Stock Units for 2025 retainer fees, which were fully vested on grant and include 26.655 units received as dividend equivalents. Under the Non-Employee Director Deferral Plan, delivery of these deferred shares is postponed until the director ceases to serve on the board.
Baker Hughes director reports deferred stock unit grant tied to 2025 fees. A company director acquired 3,494.922 Deferred Stock Units on December 15, 2025 as part of their 2025 board retainer under the Non-Employee Director Deferral Plan. Each unit represents a right to receive one share of Baker Hughes Class A Common Stock.
The units were fully vested on the grant date, but delivery of the underlying shares will occur when the director ceases to serve on the board. The reported amount includes 27.955 Deferred Stock Units credited as dividend equivalents, and the holding is reported as directly owned by the director.
Baker Hughes Co director equity grant and deferral
A Baker Hughes Co director reported receiving 3,221.396 deferred stock units on December 15, 2025. Each deferred stock unit represents the right to receive one share of Baker Hughes Class A common stock. The reported amount includes 25.513 deferred stock units credited as dividend equivalents.
The units were fully vested on the grant date. Under the company’s Non-Employee Director Deferral Plan, the director elected to take their 2025 board retainer in stock and to delay delivery of the underlying shares until they stop serving as a director.